H.I.G. Capital, a major player in the global investment landscape, continues to expand its influence with strategic acquisitions and divestitures across various sectors. With a robust portfolio valued at $65 billion, the Miami-based firm is keenly focused on identifying opportunities that promise growth and innovation.
Recently, H.I.G. Capital made headlines with its acquisition of SkinCure Oncology, a leader in non-invasive cancer treatments. This acquisition underscores H.I.G.’s commitment to advancing healthcare technologies. SkinCure Oncology, known for its image-guided superficial radiation therapy, has partnered with hundreds of physicians, bringing innovative solutions to a significant number of patients nationwide.
In a parallel move, H.I.G. Capital sold BIOVECTRA, a contract development and manufacturing organization, to Agilent Technologies for a substantial $925 million. This sale follows a period of transformation under H.I.G.’s guidance, where BIOVECTRA strengthened its market position and expanded its operational capabilities.
Diversifying its portfolio further, H.I.G. Capital has also invested in Naturalia Tantum, an Italian company specializing in organic beauty and personal care products. This move into the natural consumer market highlights the firm’s adaptive investment strategy, capturing opportunities in rapidly growing industries.
Moreover, H.I.G. Capital’s expansion is not limited to healthcare alone. The recent acquisition of Action Elevator illustrates its interest in infrastructure services, especially those that support critical sectors like healthcare.
Through these strategic maneuvers, H.I.G. Capital is positioning itself to leverage growth in various industries. As it continues to align its investments with market trends, the firm reaffirms its role as a dynamic and influential force in the global investment arena.